Shamal Az-Zour Al-Oula Power and Water Company KSC (Public) (KWSE:AZNOULA)

Ligand Pharmaceuticals Cash Flow Statement

Financials in millions KWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	12.8	9.21	12.6	14.46	13.54	12.27
Depreciation & Amortization	0.05	0.05	0.04	0.03	0.03	0.05
Loss (Gain) on Sale of Assets	-0	0	-0.01	-0.01	0	-0
Change in Accounts Receivable	-2.45	3.04	-4.92	4.82	-5.59	5.43
Change in Accounts Payable	0.42	1.32	-0.61	-1.15	0.2	-4.26
Change in Other Net Operating Assets	17.88	15.06	12.23	13.48	11.49	11.15
Other Operating Activities	20.13	22.14	22.62	19.03	19.26	21.89
Operating Cash Flow	48.84	50.82	41.96	50.81	38.93	46.54
Operating Cash Flow Growth	0.29%	21.12%	-17.42%	30.51%	-16.34%	25.67%
Capital Expenditures	-0.2	-0.24	-0.05	-0.17	-0.08	-0.01
Sale of Property, Plant & Equipment	0	0	0.01	0.01	0	0
Investing Cash Flow	-0.2	-0.24	-0.04	-0.16	-0.08	-0.01
Long-Term Debt Repaid	-	-16.64	-16.65	-17.6	-16.39	-16.24
Net Debt Issued (Repaid)	-19.64	-16.64	-16.65	-17.6	-16.39	-16.24
Common Dividends Paid	-7.39	-5.47	-10.49	-19.34	-23	-22.54
Other Financing Activities	-19.28	-21.57	-21.98	-18.37	-18.67	-21.97
Financing Cash Flow	-46.3	-43.69	-49.12	-55.3	-58.06	-60.74
Foreign Exchange Rate Adjustments	-0.66	0.58	0.18	-0.06	-0.03	-0.17
Net Cash Flow	1.68	7.47	-7.02	-4.71	-19.24	-14.39
Free Cash Flow	48.64	50.58	41.91	50.64	38.85	46.52
Free Cash Flow Growth	0.04%	20.67%	-17.23%	30.35%	-16.50%	26.09%
Free Cash Flow Margin	97.53%	103.93%	79.62%	96.01%	77.47%	90.52%
Free Cash Flow Per Share	0.04	0.05	0.04	0.05	0.04	0.04
Cash Interest Paid	19.28	21.57	21.98	18.37	18.67	21.97
Levered Free Cash Flow	2.26	7.55	-2.03	13.6	2.81	16.96
Unlevered Free Cash Flow	14.43	21.06	11.71	25.05	14.42	30.43
Change in Working Capital	15.86	19.42	6.71	17.15	6.11	12.32

Source: S&P Global Market Intelligence. Utility template. Financial Sources.